The PE Ratio as of December 2025 (TTM) for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is 41.80

According to Chengdu Easton Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 41.80. This represents a change of 20.24% compared to the average of 34.76 of the last 4 quarters.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Historical PE Ratio (quarterly & annually)

How has 688513.SS PE Ratio performed in the past?

The mean historical PE Ratio of Chengdu Easton Biopharmaceuticals Co., Ltd. over the last ten years is 45.93. The current 41.80 PE Ratio has changed 9.00% with respect to the historical average. Over the past ten years (40 quarters), 688513.SS's PE Ratio was at its highest in in the December 2015 quarter at 115.52. The PE Ratio was at its lowest in in the June 2021 quarter at 12.34.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chengdu Easton Biopharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Average PE Ratio

How has 688513.SS PE Ratio performed in the past?

The current PE Ratio of Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) PE Ratio vs. Peers

How is 688513.SS’s PE Ratio compared to its peers?

Chengdu Easton Biopharmaceuticals Co., Ltd.’s PE Ratio is greater than Shanghai Haohai Biological Technology Co., Ltd. (26.68), less than Chengdu Kanghua Biological Products Co., Ltd. (53.83), greater than Aurisco Pharmaceutical Co.,Ltd. (20.95), less than Anhui Huaheng Biotechnology Co., Ltd. (46.46), less than Zhejiang Ausun Pharmaceutical Co., Ltd. (42.97), greater than Zhejiang Jolly Pharmaceutical Co.,LTD (19.77), less than Chengzhi Shareholding Co., Ltd. (83.70), less than Chengdu Olymvax Biopharmaceuticals Inc. (164.28), greater than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (35.66), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (8.95),

Build a custom stock screener for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chengdu Easton Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chengdu Easton Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.